VSee Health Inc. (NASDAQ: VSEE), saw its stock almost triple on Friday due to an exciting new partnership.
This collaboration aims at improving intensive care units by integrating VSee telehealth technology with Ava’s robot systems. This allows for remote, personalized care of patients.
VSee’s software will be embedded into Ava robots as part of the newly announced partnership, enhancing telehealth service.
According to a press release issued by the two companies, this integration will extend advanced medical treatment from large hospitals to smaller regional and local intensive care units in the United States.
Stocks remain significantly below despite impressive jump
VSee Health stock price nearly tripled on Friday.
This dramatic increase was accompanied with a surge in the trading volume. Over 6 million shares were traded, far exceeding the average daily volume (163,000 shares).
Despite this impressive increase, VSee Health’s stock is still significantly below the high it reached for the year to date in early June.
Imo Aisiku (Co-CEO, VSee Health) emphasized telehealth’s importance as a transformative technology in modern medicine.
He expressed his confidence that the partnership between Ava Robotics and the National Institutes of Health would democratize the access to high-quality, critical care throughout the country. This would allow top-tier doctors to reach patients in the most remote areas.
Investors are advised to proceed cautiously despite the dramatic rise of VSee Health’s share price.
The current price of the stock, which is below $10, makes it vulnerable to market manipulation.
Investors should be aware of these risks when considering whether to invest in VSee Health or expand their existing positions.
The stock was trading for $4.38 at the time of this writing, down from its opening highs of $5.25.
Recent developments at VSee Health
VSee Health, in addition to its partnership Ava Robotics has been active in expanding their reach and capabilities.
Last week, the company announced that it would be collaborating with SkywardRX in order to provide telehealth services and billing to a variety of clients, including nonprofits and Fortune 20 corporations.
This move demonstrates VSee Health’s commitment towards improving healthcare access and delivery, especially for vulnerable populations.
Recently, the company appointed two new independent directors to its board, David L. Wickersham, and Cydonii V. Fairfax.
VSee Health, through its subsidiary iDoc Telehealth Solutions secured a contract last month to provide special medical services to the U.S. Federal Bureau of Prisons.
Investors should remember that VSee Health currently does not offer a dividend. This makes it less attractive to income-focused investors.
As the company navigates through this period of growth, it will be important to keep an eye on future developments and its market performance.
This post Why did VSee Health’s (VSEE) stock rise more than 200% today. This post may be updated as new information becomes available.
This site is for entertainment only. Click here to read more
